BioCentury
ARTICLE | Clinical News

PredicTOR diagnostic data

September 24, 2012 7:00 AM UTC

An exploratory study analyzing tumor samples surgically removed prior to treatment with Herceptin trastuzumab from 45 patients with HER2-positive breast cancer showed that 20/20 GeneSystems' PredicTOR...